What is the primary mechanism of opioid analgesics and key safety concerns in chronic noncancer pain management?

• A. Serotonin reuptake inhibition; risk of hyponatremia
• B. Local anesthetic blockade
• C. NMDA receptor antagonism
• D. Mu-opioid receptor agonists; tolerance, dependence, respiratory depression, misuse; require risk assessment and monitoring

Answer: (D)

Opioid analgesics work mainly by activating mu-opioid receptors in the brain and spinal cord, which inhibits the transmission of pain signals through both presynaptic and postsynaptic mechanisms. This includes reducing neurotransmitter release and increasing neuronal inhibition, effectively altering the pain perception pathway. Activation of these receptors in the brainstem also produces analgesia but is accompanied by respiratory depression and sedation, which are important safety concerns.

In chronic noncancer pain, the key risks to manage are tolerance (needing higher doses for the same effect), physical dependence, risk of misuse or developing an addiction, and the potential for respiratory depression, especially with higher doses or when combined with other central nervous system depressants. Other bothersome adverse effects like constipation, dizziness, cognitive impairment, and hormonal or immune effects also matter over long-term use.

Because of these risks, risk assessment and ongoing monitoring are essential. Start with the lowest effective dose and reassess regularly, consider non-opioid or multimodal approaches when possible, use tools such as prescription monitoring programs, urine drug testing as appropriate, and patient education. In higher-risk scenarios, plan for closer follow-up and strategies like naloxone co-prescribing or opioid stewardship approaches to minimize harm.